CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to PFE

Pertuzumab

Phase 3
PFIZER (PFE)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Nov '26
PFEPhase 2

Pertuzumab Phase 2 Est. Readout (BRIDGET)

Pertuzumab
Nov 2026~
CT.gov
00%
Competitive Landscape

3 competitors in HER2 Positive Breast Cancer

View Full Landscape
Drug Information

Target Indication

HER2 Positive Breast Cancer

Clinical Trial

NCT05132582

Last updated: 1/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.